PTC Therapeutics Inc - Asset Resilience Ratio

Latest as of March 2026: 36.89%

PTC Therapeutics Inc (PTCT) has an Asset Resilience Ratio of 36.89% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PTCT current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$1.06 Billion

Cash + Short-term Investments

Total Assets

$2.87 Billion

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2004–2025)

This chart shows how PTC Therapeutics Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see PTC Therapeutics Inc total assets.

Liquid Assets Composition Over Time

This chart breaks down PTC Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read PTC Therapeutics Inc total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$1.06 Billion	36.89%
Total Liquid Assets	$1.06 Billion	36.89%

Asset Resilience Insights

Very High Liquidity: PTC Therapeutics Inc maintains exceptional liquid asset reserves at 36.89% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

PTC Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare PTC Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for PTC Therapeutics Inc (2004–2025)

The table below shows the annual Asset Resilience Ratio data for PTC Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	33.00%	$960.72 Million	$2.91 Billion	+11.89pp
2024-12-31	21.11%	$359.99 Million	$1.71 Billion	+6.20pp
2023-12-31	14.91%	$282.74 Million	$1.90 Billion	+7.24pp
2022-12-31	7.67%	$130.87 Million	$1.71 Billion	-22.44pp
2021-12-31	30.12%	$583.66 Million	$1.94 Billion	-10.41pp
2020-12-31	40.52%	$894.84 Million	$2.21 Billion	+15.98pp
2019-12-31	24.54%	$398.54 Million	$1.62 Billion	+19.35pp
2018-12-31	5.19%	$58.09 Million	$1.12 Billion	-15.10pp
2017-12-31	20.29%	$79.45 Million	$391.65 Million	-44.07pp
2016-12-31	64.36%	$173.34 Million	$269.35 Million	-11.97pp
2015-12-31	76.32%	$280.90 Million	$368.04 Million	-3.35pp
2014-12-31	79.68%	$265.49 Million	$333.22 Million	-3.97pp
2013-12-31	83.64%	$127.05 Million	$151.90 Million	+22.52pp
2005-12-31	61.12%	$26.88 Million	$43.97 Million	-6.14pp
2004-12-31	67.26%	$26.21 Million	$38.97 Million	--

pp = percentage points

About PTC Therapeutics Inc

NASDAQ:PTCT USA Biotechnology

Market Cap

$5.45 Billion

Market Cap Rank

#3362 Global

#1187 in USA

Share Price

$65.65

Change (1 day)

-1.25%

52-Week Range

$57.84 - $89.55

All Time High

$89.55